KNSA logo

Kiniksa Pharmaceuticals (KNSA) Long Term Liabilities

Annual Total Long Term Liabilities

$23.82 M
+$7.36 M+44.72%

December 31, 2023


Summary


Performance

KNSA Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKNSAbalance sheetmetrics:

Quarterly Long Term Liabilities

$22.34 M
-$705.00 K-3.06%

September 30, 2024


Summary


Performance

KNSA Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKNSAbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

KNSA Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+44.7%-8.7%
3 y3 years+319.1%+409.5%
5 y5 years+10000.0%+857.0%

KNSA Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+710.4%-11.4%+660.0%
5 y5-yearat high+1759.3%-11.4%+4622.4%
alltimeall time-80.1%>+9999.0%-81.3%>+9999.0%

Kiniksa Pharmaceuticals Long Term Liabilities History

DateAnnualQuarterly
Sep 2024
-
$22.34 M(-3.1%)
Jun 2024
-
$23.04 M(-2.2%)
Mar 2024
-
$23.57 M(-1.1%)
Dec 2023
$23.82 M(+44.7%)
$23.82 M(-2.7%)
Sep 2023
-
$24.47 M(-2.9%)
Jun 2023
-
$25.20 M(+55.8%)
Mar 2023
-
$16.18 M(-1.7%)
Dec 2022
$16.46 M(+460.0%)
$16.46 M(-15.4%)
Sep 2022
-
$19.45 M(+43.7%)
Jun 2022
-
$13.54 M(-5.8%)
Mar 2022
-
$14.37 M(+388.8%)
Dec 2021
$2.94 M
$2.94 M(-33.0%)
Sep 2021
-
$4.38 M(-5.5%)
Jun 2021
-
$4.64 M(-7.3%)
DateAnnualQuarterly
Mar 2021
-
$5.01 M(-11.9%)
Dec 2020
$5.68 M(+343.6%)
$5.68 M(+461.6%)
Sep 2020
-
$1.01 M(+114.0%)
Jun 2020
-
$473.00 K(-49.2%)
Mar 2020
-
$932.00 K(-27.2%)
Dec 2019
$1.28 M(+789.6%)
$1.28 M(-45.1%)
Sep 2019
-
$2.33 M(-15.5%)
Jun 2019
-
$2.76 M(+0.5%)
Mar 2019
-
$2.75 M(+1808.3%)
Dec 2018
$144.00 K(-99.9%)
$144.00 K(-13.8%)
Sep 2018
-
$167.00 K(-10.2%)
Jun 2018
-
$186.00 K(+520.0%)
Mar 2018
-
$30.00 K(-100.0%)
Dec 2017
$119.77 M(+49.9%)
$119.77 M
Dec 2016
$79.90 M
-

FAQ

  • What is Kiniksa Pharmaceuticals annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual total long term liabilities year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly long term liabilities year-on-year change?

What is Kiniksa Pharmaceuticals annual total long term liabilities?

The current annual total long term liabilities of KNSA is $23.82 M

What is the all time high annual total long term liabilities for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual total long term liabilities is $119.77 M

What is Kiniksa Pharmaceuticals annual total long term liabilities year-on-year change?

Over the past year, KNSA annual total long term liabilities has changed by +$7.36 M (+44.72%)

What is Kiniksa Pharmaceuticals quarterly total long term liabilities?

The current quarterly long term liabilities of KNSA is $22.34 M

What is the all time high quarterly long term liabilities for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly total long term liabilities is $119.77 M

What is Kiniksa Pharmaceuticals quarterly long term liabilities year-on-year change?

Over the past year, KNSA quarterly total long term liabilities has changed by -$2.13 M (-8.71%)